SCHEMBL6938267

SCHEMBL6938267

CC1=CN(CC(=O)c2ccc(Br)cc2)CS1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
KMT2A Q03164 1/20 0.45
GSK3B P49841 3/20 0.42
MAPT P10636 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
HTT P42858 1/20 0.42
RAB9A P51151 1/20 0.42
LMNA P02545 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
MAPK1 P28482 1/20 0.42
CYP2C19 P33261 1/20 0.42
GAA P10253 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CXCR3 P49682 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL2945063 0.99 ALDH1A1 (0.45) ALDH1A1KMT2AGSK3BMAPTSMN1; SMN2
Bromide SCHEMBL4078658 0.95 ALDH1A1 (0.42) ALDH1A1KMT2AGSK3BMAPTSMN1; SMN2
SCHEMBL6936500 0.85 GSK3A (0.44) ALDH1A1KMT2AGSK3BMAPTSMN1; SMN2
Bromide SCHEMBL3963512 0.84 GSK3A (0.43) ALDH1A1KMT2AGSK3BMAPTSMN1; SMN2
SCHEMBL6938200 0.73 ALDH1A1 (0.49) ALDH1A1KMT2AGSK3BMAPTSMN1; SMN2
SCHEMBL6935144 0.73 GSK3B (0.44) ALDH1A1KMT2AGSK3BMAPTSMN1; SMN2
Bromide SCHEMBL3851561 0.72 MAPT (0.50) ALDH1A1KMT2AGSK3BMAPTSMN1; SMN2
Bromide SCHEMBL2947798 0.72 RAB9A (0.46) ALDH1A1KMT2AGSK3BMAPTSMN1; SMN2
SCHEMBL4255420 0.71 MAPT (0.48) ALDH1A1KMT2AGSK3BMAPTSMN1; SMN2
SCHEMBL28841430 0.70 ALDH1A1 (0.48) ALDH1A1KMT2AGSK3BMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0808163-B1 USE OF THIAZOLIUM COMPOUNDS FOR PREVENTING AND REVERSING THE FORMATION OF ADVANCED GLYCOSYLATION ENDPRODUCTS ALTEON INC (US) 2003-07-23 EP claimed
US-6440749-B1 ADMINISTERING A THIAZOLE COMPOUND ALTEON. INC. 2002-08-27 US claimed